{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:03:40Z","timestamp":1790820220074,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005694","name":"Hori Sciences and Arts Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00062","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T23:24:39Z","timestamp":1549927479000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":93,"title":["EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment"],"prefix":"10.3389","volume":"9","author":[{"given":"Hiroshi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yok-Lam","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"key":"B1","first-page":"1898","article-title":"Epstein-Barr virus","volume-title":"Fields Virology","author":"Longnecker","year":"2013"},{"key":"B2","first-page":"305","article-title":"Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease","volume-title":"Rev Med Virol.","author":"Kimura","year":"2008"},{"key":"B3","first-page":"475","article-title":"The biology and clinical utility of EBV monitoring in blood","volume-title":"Curr Top Microbiol Immunol.","author":"Kanakry","year":"2015"},{"key":"B4","first-page":"1472","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume-title":"Ann Oncol.","author":"Cohen","year":"2009"},{"key":"B5","first-page":"169","article-title":"Epstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasms","volume-title":"Nagoya J Med Sci.","author":"Kimura","year":"2013"},{"key":"B6","first-page":"1328","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume-title":"N Engl J Med.","author":"Thorley-Lawson","year":"2004"},{"key":"B7","first-page":"459","article-title":"EBV in T-\/NK-cell tumorigenesis","volume-title":"Adv Exp Med Biol.","author":"Kimura","year":"2018"},{"key":"B8","first-page":"1188","article-title":"Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma","volume-title":"Cancer Res.","author":"Lo","year":"1999"},{"key":"B9","first-page":"489","article-title":"Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma","volume-title":"Semin Cancer Biol.","author":"Chan","year":"2002"},{"key":"B10","first-page":"513","article-title":"Analysis of plasma epstein-barr virus DNA to screen for nasopharyngeal cancer","volume-title":"N Engl J Med.","author":"Chan","year":"2017"},{"key":"B11","first-page":"132","article-title":"Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay","volume-title":"J Clin Microbiol","author":"Kimura","year":"1999"},{"key":"B12","first-page":"986","article-title":"Real time quantitative PCR","volume-title":"Genome Res.","author":"Heid","year":"1996"},{"key":"B13","first-page":"423","article-title":"A collaborative study to establish the 1st WHO International Standard for Epstein-Barr virus for nucleic acid amplification techniques","volume-title":"Biologicals","author":"Fryer","year":"2016"},{"key":"B14","first-page":"8604","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume-title":"Anal Chem.","author":"Hindson","year":"2011"},{"key":"B15","first-page":"369","article-title":"Digital assays part i: partitioning statistics and digital PCR","volume-title":"SLAS Technol.","author":"Basu","year":"2017"},{"key":"B16","first-page":"1616","article-title":"Quantitative assessment of commutability for clinical viral load testing using a digital PCR-Based reference standard","volume-title":"J Clin Microbiol.","author":"Tang","year":"2016"},{"key":"B17","first-page":"3944","article-title":"replication of human herpesviruses is associated with higher HIV DNA levels during antiretroviral therapy started at early phases of HIV infection","volume-title":"J Virol.","author":"Gianella","year":"2016"},{"key":"B18","first-page":"16","article-title":"Digital PCR as a tool to measure HIV persistence","volume-title":"Retrovirology","author":"Rutsaert","year":"2018"},{"key":"B19","first-page":"778","article-title":"Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis","volume-title":"Clin Exp Rheumatol.","author":"Kuusela","year":"2018"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1111\/ceo.13440","article-title":"Digital droplet polymerase chain reaction analysis of common viruses in the aqueous humour of patients with Posner-Schlossman syndrome in Chinese population","volume-title":"Clin Exp Ophthalmol.","author":"Cao","year":"2018"},{"key":"B21","first-page":"32","article-title":"Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls","volume-title":"Infect Agent Cancer","author":"Lin","year":"2016"},{"key":"B22","first-page":"72","article-title":"Quantitative nucleic acid amplification methods for viral infections","volume-title":"Clin Chem.","author":"Gullett","year":"2015"},{"key":"B23","first-page":"453","article-title":"Post transplant lymphoproliferative disorders","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"B24","first-page":"549","article-title":"Post-Transplantation Lymphoproliferative Disorders in Adults","volume-title":"N Engl J Med.","author":"Dierickx","year":"2018"},{"key":"B25","first-page":"105","article-title":"Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation","volume-title":"Br J Haematol.","author":"Hoshino","year":"2001"},{"key":"B26","first-page":"1143","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume-title":"Biol Blood Marrow Transplant.","author":"Tomblyn","year":"2009"},{"key":"B27","first-page":"803","article-title":"Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: sixth European Conference on Infections in Leukemia (ECIL-6) guidelines","volume-title":"Haematologica","author":"Styczynski","year":"2016"},{"key":"B28","first-page":"330","article-title":"Management of post-transplant lymphoproliferative disorders","volume-title":"Br J Haematol.","author":"DeStefano","year":"2018"},{"key":"B29","first-page":"1016","article-title":"EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial","volume-title":"Am J Transplant.","author":"Tsai","year":"2008"},{"key":"B30","first-page":"186","article-title":"Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation","volume-title":"J Clin Virol.","author":"Ruf","year":"2012"},{"key":"B31","first-page":"1426","article-title":"Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay","volume-title":"J Clin Microbiol.","author":"Wada","year":"2007"},{"key":"B32","first-page":"537","article-title":"Comprehensive review of post-organ transplant hematologic cancers","volume-title":"Am J Transplant.","author":"Dharnidharka","year":"2018"},{"key":"B33","first-page":"675","article-title":"Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines","volume-title":"Br J Haematol.","author":"Parker","year":"2010"},{"key":"B34","first-page":"461","article-title":"Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads","volume-title":"J Infect Dis.","author":"Gotoh","year":"2010"},{"key":"B35","first-page":"435","article-title":"Classic Hodgkin lymphoma","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2017"},{"key":"B36","first-page":"502","article-title":"Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease","volume-title":"N Engl J Med","author":"Weiss","year":"1989"},{"key":"B37","first-page":"61","article-title":"Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies","volume-title":"Diagn Mol Pathol.","author":"Ryan","year":"2004"},{"key":"B38","first-page":"3547","article-title":"Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial","volume-title":"Blood","author":"Kanakry","year":"2013"},{"key":"B39","first-page":"368","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan","year":"2017"},{"key":"B40","first-page":"85","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume-title":"J Hematol Oncol.","author":"Tse","year":"2017"},{"key":"B41","first-page":"29","article-title":"Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer\/T-cell lymphoma","volume-title":"Clin Cancer Res.","author":"Lei","year":"2002"},{"key":"B42","first-page":"243","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume-title":"Blood","author":"Au","year":"2004"},{"key":"B43","first-page":"6018","article-title":"Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type","volume-title":"Blood","author":"Suzuki","year":"2011"},{"key":"B44","first-page":"4183","article-title":"Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type","volume-title":"Clin Cancer Res.","author":"Ito","year":"2012"},{"key":"B45","first-page":"865","article-title":"Quantification of circulating Epstein-Barr virus DNA in NK\/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance","volume-title":"Leukemia","author":"Kwong","year":"2014"},{"key":"B46","first-page":"1427","article-title":"Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma","volume-title":"Ann Hematol.","author":"Cho","year":"2018"},{"key":"B47","first-page":"389","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume-title":"Lancet Oncol.","author":"Kim","year":"2016"},{"key":"B48","first-page":"673","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume-title":"Blood","author":"Kimura","year":"2012"},{"key":"B49","first-page":"1867","article-title":"Chronic active epstein-barr virus disease","volume-title":"Front Immunol.","author":"Kimura","year":"2017"},{"key":"B50","first-page":"355","article-title":"EBV\u2013positive T-cell and NK-cell lymphoproliferative diseases of childhood","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Quintanilla-Martinez","year":"2017"},{"key":"B51","first-page":"64","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume-title":"Am J Hematol.","author":"Okano","year":"2005"},{"key":"B52","first-page":"280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume-title":"Blood","author":"Kimura","year":"2001"},{"key":"B53","first-page":"268","article-title":"Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease","volume-title":"J Infect Chemother.","author":"Ito","year":"2016"},{"key":"B54","first-page":"79","article-title":"Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease","volume-title":"Transpl Infect Dis.","author":"Rowe","year":"2001"},{"key":"B55","first-page":"350","article-title":"Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder","volume-title":"Clin Microbiol Rev.","author":"Gulley","year":"2010"},{"key":"B56","first-page":"129","article-title":"Automated nucleic acid extraction systems for detecting cytomegalovirus and epstein-barr virus using real-time PCR: a comparison study between the QIAsymphony RGQ and QIAcube systems","volume-title":"Ann Lab Med.","author":"Kim","year":"2017"},{"key":"B57","first-page":"428","article-title":"Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system","volume-title":"Diagn Microbiol Infect Dis.","author":"Salmona","year":"2016"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T23:24:47Z","timestamp":1549927487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":57,"alternative-id":["10.3389\/fonc.2019.00062"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00062","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"article-number":"62"}}